Adjuvant treatment of early-stage melanoma by local i.d. administration of low-dose CpG-B and GM-CSF increases recurrence-free survival: long-term follow-up of three randomized clinical trials
================================================================================================================================================================================================

* Tanja D de Gruijl
* Bas D Koster
* Mari FCM van den Hout
* Berbel JR Sluijter
* Barbara G Molenkamp
* Ronald JCLM Vuylsteke
* Paul AM van Leeuwen
* Rik J Scheper
* Petrousjka van den Tol
* Alfons van den Eertwegh